Cargando…

Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling

BACKGROUND: Epidemiological studies have shown that the offspring of mothers who experience diabetes mellitus during pregnancy are seven times more likely to develop health complications than the offspring of mothers who do not suffer from diabetes during pregnancy. The present study was designed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Badr, Gamal, Mahmoud, Mohamed H, Farhat, Karim, Waly, Hanan, Al-Abdin, Osman Zin, Rabah, Danny M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608164/
https://www.ncbi.nlm.nih.gov/pubmed/23506302
http://dx.doi.org/10.1186/1476-511X-12-37
_version_ 1782264196960878592
author Badr, Gamal
Mahmoud, Mohamed H
Farhat, Karim
Waly, Hanan
Al-Abdin, Osman Zin
Rabah, Danny M
author_facet Badr, Gamal
Mahmoud, Mohamed H
Farhat, Karim
Waly, Hanan
Al-Abdin, Osman Zin
Rabah, Danny M
author_sort Badr, Gamal
collection PubMed
description BACKGROUND: Epidemiological studies have shown that the offspring of mothers who experience diabetes mellitus during pregnancy are seven times more likely to develop health complications than the offspring of mothers who do not suffer from diabetes during pregnancy. The present study was designed to investigate whether supplementation of streptozotocin (STZ)-induced diabetic pregnant mice with thymoquinone (TQ) during pregnancy and lactation improves the risk of developing diabetic complications acquired by their offspring. METHODS: Three groups of pregnant female mice were used: non-diabetic control dams (CD), diabetic dams (DD), and diabetic dams supplemented with TQ (DD + TQ) during pregnancy and lactation (n = 10 female mice in each group). RESULTS: Our data demonstrated a marked decrease in the number of neonates born to DD, and these neonates showed a marked increase in their mean body weight (macrosomic pups) compared to those born to CD and DD + TQ. The induction of diabetes during pregnancy and lactation resulted in macrosomic pups with several postpartum complications, such as a marked increase in their levels of blood glucose, free radicals, plasma pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), and lipids, and a tendency toward abnormal obesity compared to the offspring of CD. By contrast, macrosomic offspring born to DD exhibited a marked reduction in plasma cytokine levels (IL-2, -4 and -7), an obvious reduction in the number of circulating lymphocytes, decreased proliferation of superantigen (SEB)-stimulated lymphocytes and aberrant AKT phosphorylation. Interestingly, the supplementation of DD with TQ during pregnancy and lactation had an obvious and significant effect on the number and mean body weight of neonates. Furthermore, TQ significantly restored the levels of blood glucose, insulin, free radicals, plasma cytokines, and lipids as well as lymphocyte proliferation in the offspring. CONCLUSIONS: Our data suggest that the nutritional supplementation of DD with the natural antioxidant TQ during pregnancy and lactation protects their offspring from developing diabetic complications and preserves an efficient lymphocyte immune response later in life.
format Online
Article
Text
id pubmed-3608164
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36081642013-03-27 Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling Badr, Gamal Mahmoud, Mohamed H Farhat, Karim Waly, Hanan Al-Abdin, Osman Zin Rabah, Danny M Lipids Health Dis Research BACKGROUND: Epidemiological studies have shown that the offspring of mothers who experience diabetes mellitus during pregnancy are seven times more likely to develop health complications than the offspring of mothers who do not suffer from diabetes during pregnancy. The present study was designed to investigate whether supplementation of streptozotocin (STZ)-induced diabetic pregnant mice with thymoquinone (TQ) during pregnancy and lactation improves the risk of developing diabetic complications acquired by their offspring. METHODS: Three groups of pregnant female mice were used: non-diabetic control dams (CD), diabetic dams (DD), and diabetic dams supplemented with TQ (DD + TQ) during pregnancy and lactation (n = 10 female mice in each group). RESULTS: Our data demonstrated a marked decrease in the number of neonates born to DD, and these neonates showed a marked increase in their mean body weight (macrosomic pups) compared to those born to CD and DD + TQ. The induction of diabetes during pregnancy and lactation resulted in macrosomic pups with several postpartum complications, such as a marked increase in their levels of blood glucose, free radicals, plasma pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), and lipids, and a tendency toward abnormal obesity compared to the offspring of CD. By contrast, macrosomic offspring born to DD exhibited a marked reduction in plasma cytokine levels (IL-2, -4 and -7), an obvious reduction in the number of circulating lymphocytes, decreased proliferation of superantigen (SEB)-stimulated lymphocytes and aberrant AKT phosphorylation. Interestingly, the supplementation of DD with TQ during pregnancy and lactation had an obvious and significant effect on the number and mean body weight of neonates. Furthermore, TQ significantly restored the levels of blood glucose, insulin, free radicals, plasma cytokines, and lipids as well as lymphocyte proliferation in the offspring. CONCLUSIONS: Our data suggest that the nutritional supplementation of DD with the natural antioxidant TQ during pregnancy and lactation protects their offspring from developing diabetic complications and preserves an efficient lymphocyte immune response later in life. BioMed Central 2013-03-18 /pmc/articles/PMC3608164/ /pubmed/23506302 http://dx.doi.org/10.1186/1476-511X-12-37 Text en Copyright ©2013 Badr et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Badr, Gamal
Mahmoud, Mohamed H
Farhat, Karim
Waly, Hanan
Al-Abdin, Osman Zin
Rabah, Danny M
Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title_full Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title_fullStr Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title_full_unstemmed Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title_short Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling
title_sort maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via pi3k/akt signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608164/
https://www.ncbi.nlm.nih.gov/pubmed/23506302
http://dx.doi.org/10.1186/1476-511X-12-37
work_keys_str_mv AT badrgamal maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling
AT mahmoudmohamedh maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling
AT farhatkarim maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling
AT walyhanan maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling
AT alabdinosmanzin maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling
AT rabahdannym maternalsupplementationofdiabeticmicewiththymoquinoneprotectstheiroffspringfromabnormalobesityanddiabetesbymodulatingtheirlipidprofileandfreeradicalproductionandrestoringlymphocyteproliferationviapi3kaktsignaling